SCHEMBL3985166

SCHEMBL3985166

O=Cc1ccc(CC#CCO)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH5A1 P51649 1/20 0.41
ABAT P80404 1/20 0.41
EGFR P00533 2/20 0.38
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP2A6 P11509 3/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.36
ALDH3A1 P30838 1/20 0.35
ALDH1A3 P47895 1/20 0.35
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
TYR P14679 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2560937 0.78 MMP2 (0.47) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL11130220 0.78 CYP2A6 (0.38) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL8329657 0.76 CYP2A6 (0.44) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL1124751 0.73 ALDH5A1 (0.52) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL27034753 0.73 CYP2A6 (0.39) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL2563564 0.72 EGFR (0.47) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL10799608 0.72 KCNH2 (0.45) CYP2A6LMNAKMT2A
SCHEMBL4137976 0.72 CYP2A6 (0.41) ALDH5A1ABATEGFRALDH1A1KDM4E
SCHEMBL7461859 0.72 FFAR1 (0.53) ALDH1A1KDM4EHSD17B10LMNAMAPT
SCHEMBL14068217 0.72 ALDH1A1 (0.44) ALDH1A1KDM4ECYP2A6LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015069110-A1 MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS AAPA B.V. (NL) 2015-05-14 WO disclosed
EP-2061449-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES Leo Pharma A/S (DK) 2009-05-27 EP disclosed
WO-2008019690-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2008-02-21 WO disclosed